(19)
(11) EP 1 235 841 A1

(12)

(43) Date of publication:
04.09.2002 Bulletin 2002/36

(21) Application number: 00984183.4

(22) Date of filing: 11.12.2000
(51) International Patent Classification (IPC)7C07H 21/02, C07H 21/04, C07H 21/00, A61K 38/04, A61K 35/08, A61K 38/10, A61K 38/16, A61K 39/00, A61K 48/00, C07K 9/00, C07K 7/00, C07K 11/00
(86) International application number:
PCT/US0033/545
(87) International publication number:
WO 0104/2267 (14.06.2001 Gazette 2001/24)
(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR
Designated Extension States:
AL LT LV MK RO SI

(30) Priority: 10.12.1999 US 458298

(71) Applicant: Epimmune Inc.
San Diego, CA 92121 (US)

(72) Inventors:
  • FIKES, John
    San Diego, CA 92122 (US)
  • SETTE, Alessandro
    La Jolla, CA 92037 (US)
  • SIDNEY, John
    San Diego, CA 92130 (US)
  • SOUTHWOOD, Scott
    Santee, CA 92071 (US)
  • CHESNUT, Robert
    Cardiff-by-the-Sea, CA 92007 (US)
  • CELIS, Esteban
    Rochester, MN 55902 (US)
  • KEOGH, Elissa
    San Diego, CA 92121 (US)

(74) Representative: Cripps, Joanna Elizabeth et al
Mewburn EllisYork House23 Kingsway
London WC2B 6HP
London WC2B 6HP (GB)

   


(54) INDUCING CELLULAR IMMUNE RESPONSES TO MAGE2/3 USING PEPTIDE AND NUCLEIC ACID COMPOSITIONS